0001562180-23-006433.txt : 20230818
0001562180-23-006433.hdr.sgml : 20230818
20230818160338
ACCESSION NUMBER: 0001562180-23-006433
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230816
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Agresta Samuel
CENTRAL INDEX KEY: 0001748961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 231185848
MAIL ADDRESS:
STREET 1: 784 MEMORIAL DR.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-08-16
false
0001822462
Foghorn Therapeutics Inc.
FHTX
0001748961
Agresta Samuel
500 TECHNOLOGY SQUARE
STE 700
CAMBRIDGE
MA
02139
false
true
false
false
Chief Medical Officer
false
Common Stock
2023-08-16
4
M
false
311297.00
3.72
A
311297.00
D
Common Stock
2023-08-16
4
S
false
311297.00
8.25
D
0.00
D
Stock Option (right to buy)
3.72
2023-08-16
4
M
false
311297.00
0.00
D
2029-09-16
Common Stock
311297.00
0.00
D
The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until fully vested.
/s /Allan Reine, M.D., Attorney-in-Fact
2023-08-18